Fulcrum Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-31,942
Closed -$11.6M 255
2025
Q1
$11.6M Buy
+31,942
New +$12.8M 2.25% 8

Other funds holding ELV

Fulcrum Asset Management's ELV Position: Q2 2026 in Review

Fulcrum Asset Management reduced its Elevance Health (ELV) stake by 81% in Q2 2026, selling an estimated $1.55M and leaving 1,009 shares worth $392K. The position accounts for 0.04% of the portfolio, ranked #314.

Fulcrum Asset Management first reported a position in ELV in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.92M in Q2 2025. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Fulcrum Asset Management held 1,009 shares of Elevance Health worth $392K as of Q2 2026.
  • Fulcrum Asset Management sold 4,186 Elevance Health shares in Q2 2026, an estimated $1.55M.
  • Elevance Health made up 0.04% of Fulcrum Asset Management's portfolio in Q2 2026, its #314 holding.
  • Fulcrum Asset Management first reported a position in Elevance Health in Q2 2025 and has held it in 5 quarters since.
  • Fulcrum Asset Management's Elevance Health position peaked at $2.92M in Q2 2025.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Fulcrum Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.